NMN+
Built for cellular vitality.
Beta‑Nicotinamide Mononucleotide and Trans‑Resveratrol, two of the most studied molecules in longevity research, paired with Black Pepper Extract for absorption.
Beta‑Nicotinamide Mononucleotide 500 mg +
The molecule behind most of the longevity research you've read about in recent years.
Beta‑Nicotinamide Mononucleotide is a nucleotide compound found naturally in small amounts in foods such as avocado, broccoli, and edamame. In biochemistry, NMN is classified as a direct precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme central to mitochondrial energy metabolism. It is one of the most actively researched molecules in longevity science. In NMN+, it is paired with Trans‑Resveratrol, a polyphenol studied alongside NMN in sirtuin research, and Black Pepper Extract, added specifically for bioavailability.Trans‑Resveratrol 600 mg +
The polyphenol from red grape skins that made the Mediterranean diet famous.
Trans‑Resveratrol is the stable, bioactive isomer of resveratrol, a polyphenol found in red grape skins and in Japanese knotweed (Polygonum cuspidatum), the source used in most commercial extracts. It belongs to a family of compounds called stilbenes and is frequently studied in research on sirtuin pathways and cellular ageing. In NMN+, it is paired with NMN because the two molecules are often studied together in longevity research, and with Black Pepper Extract to address resveratrol's known bioavailability limitations.Black Pepper Extract 50 mg +
Not filler. It's in the formula to make the other ingredients actually work.
Black Pepper Extract is a standardised extract of Piper nigrum, the principal alkaloid of which is piperine, the compound responsible for the pungency of black pepper. Piperine has been extensively studied in pharmacokinetic research, particularly in the context of its documented effect on the bioavailability of other co‑administered compounds. In NMN+, it is included specifically to address the low oral bioavailability of Trans‑Resveratrol, a known limitation of the molecule, and to complement the absorption profile of NMN.Descriptions summarise each molecule's chemistry and research context. No approved therapeutic claims.
FDA CPR No. FR-2064943 · Valid until 14 June 2028